ArticleToxicology reports2019

Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells.

Amel B Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.